Catherine A. Forbes

1.7k total citations
32 papers, 1.2k citations indexed

About

Catherine A. Forbes is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Catherine A. Forbes has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 13 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Catherine A. Forbes's work include Immune Cell Function and Interaction (14 papers), Cytomegalovirus and herpesvirus research (12 papers) and Immunotherapy and Immune Responses (7 papers). Catherine A. Forbes is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Cytomegalovirus and herpesvirus research (12 papers) and Immunotherapy and Immune Responses (7 papers). Catherine A. Forbes collaborates with scholars based in Australia, United States and United Kingdom. Catherine A. Forbes's co-authors include Anthony A. Scalzo, Wayne M. Yokoyama, Mark J. Smyth, Kevin Thia, Erika Cretney, Marie B. Snook, Janice M. Kelly, Geoffrey Shellam, Mariapia A. Degli‐Esposti and Michael G. Brown and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Immunology and The Journal of Immunology.

In The Last Decade

Catherine A. Forbes

31 papers receiving 1.2k citations

Peers

Countries citing papers authored by Catherine A. Forbes

Since Specialization

Citations

This map shows the geographic impact of Catherine A. Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. Forbes more than expected).

Fields of papers citing papers by Catherine A. Forbes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine A. Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. Forbes. The network helps show where Catherine A. Forbes may publish in the future.

Co-authorship network of co-authors of Catherine A. Forbes

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine A. Forbes. A scholar is included among the top collaborators of Catherine A. Forbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine A. Forbes. Catherine A. Forbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying SETBP1 haploinsufficiency molecular pathways to improve patient diagnosis using induced pluripotent stem cells and neural disease modelling 2024 ·Molecular Autism ·Nicole C. Shaw, Kevin G. Chen, (unknown), (unknown), Catherine A. Forbes, (unknown), Timo Lassmann, Vanessa S. Fear	0
2	Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease 2023 ·Stem Cell Research & Therapy ·Vanessa S. Fear, Catherine A. Forbes, Nicole C. Shaw, (unknown), (unknown), (unknown), (unknown), Helena M. Viola, Henrietta Cserné Szappanos, Livia C. Hool, Michelle C. Ward, Gareth Baynam, Timo Lassmann	4
3	CRISPR-Cas9-generated PTCHD1 2489T>G stem cells recapitulate patient phenotype when undergoing neural induction 2023 ·Human Genetics and Genomics Advances ·(unknown), Catherine A. Forbes, Nicole C. Shaw, (unknown), Michelle C. Ward, Gareth Baynam, Timo Lassmann, Vanessa S. Fear	1
4	CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy 2022 ·Cell Reports ·Caitlin M. Tilsed, (unknown), (unknown), Wee Loong Chin, (unknown), Rachael M. Zemek, Jonathan Chee, (unknown), Vanessa S. Fear, Catherine A. Forbes, (unknown), Maud H.E. Jansen, Abha Chopra, Timo Lassmann, Anna K. Nowak, Scott Fisher, Richard Lake, W. Joost Lesterhuis	8
5	CRISPR single base editing, neuronal disease modelling and functional genomics for genetic variant analysis: pipeline validation using Kleefstra syndrome EHMT1 haploinsufficiency 2022 ·Stem Cell Research & Therapy ·Vanessa S. Fear, Catherine A. Forbes, Denise Anderson, Sebastian Rauschert, (unknown), Nicole C. Shaw, Sarra E. Jamieson, Michelle C. Ward, Gareth Baynam, Timo Lassmann	9
6	Functional validation of variants of unknown significance using CRISPR gene editing and transcriptomics: A Kleefstra syndrome case study 2022 ·Gene ·Vanessa S. Fear, Catherine A. Forbes, Denise Anderson, Sebastian Rauschert, (unknown), Nicole C. Shaw, Matthew Jones, Alistair R. R. Forrest, Gareth Baynam, Timo Lassmann	7
7	Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used 2021 ·Cancer Immunology Immunotherapy ·Vanessa S. Fear, Catherine A. Forbes, (unknown), Scott Fisher, Jonathan Chee, Jason Waithman, Kang Shao, Richard Lake, Anna K. Nowak, Jenette Creaney, Matthew Brown, Christobel Saunders, Bruce Robinson	28
8	Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy 2020 ·Frontiers in Immunology ·(unknown), (unknown), Siting Goh, Caitlin M. Tilsed, Scott Fisher, Vanessa S. Fear, Catherine A. Forbes, Rachael M. Zemek, Abha Chopra, Mark Watson, Ian M. Dick, Louis Boon, Robert A. Holt, Richard Lake, Anna K. Nowak, W. Joost Lesterhuis, Alison M. McDonnell, Jonathan Chee	48
9	Neo-antigen specific T cell responses indicate the presence of metastases before imaging 2019 ·Scientific Reports ·Vanessa S. Fear, Catherine A. Forbes, Jonathan Chee, Shaoping Ma, (unknown), (unknown), Scott Fisher, Ian M. Dick, Jenette Creaney, Bruce Robinson	3
10	Ly49C-Dependent Control of MCMV Infection by NK Cells Is Cis-Regulated by MHC Class I Molecules 2014 ·PLoS Pathogens ·Catherine A. Forbes, Anthony A. Scalzo, Mariapia A. Degli‐Esposti, Jérôme D. Coudert	23
11	Targeting of a natural killer cell receptor family by a viral immunoevasin 2013 ·Nature Immunology ·Richard Berry, (unknown), Philippa M. Saunders, J.P. Vivian, Jie Lin, (unknown), Alexandra J. Corbett, Catherine A. Forbes, Jacqueline Widjaja, Lucy C. Sullivan, (unknown), Matthew A. Perugini, Melissa Call, Anthony A. Scalzo, Mariapia A. Degli‐Esposti, Jérôme D. Coudert, Travis Beddoe, Andrëw G. Brööks, Jamie Rossjohn	37
12	Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK‐cell receptor Ly49H 2010 ·European Journal of Immunology ·Natalya V. Guseva, Colleen Fullenkamp, Paul Naumann, (unknown), Zuhair K. Ballas, Jon C. D. Houtman, Catherine A. Forbes, Anthony A. Scalzo, Jonathan W. Heusel	7
13	Transcriptional analysis of human cytomegalovirus and rat cytomegalovirus homologues of the M73/M73.5 spliced gene family 2008 ·Archives of Virology ·Anthony A. Scalzo, Catherine A. Forbes, L. M. Smith, Lambert C. Loh	8
14	The murine cytomegalovirus M73.5 gene, a member of a 3′ co-terminal alternatively spliced gene family, encodes the gp24 virion glycoprotein 2004 ·Virology ·Anthony A. Scalzo, Peter B. Dallas, Catherine A. Forbes, Andrew S. J. Mikosza, Peter Fleming, Louise J. Lathbury, Paul Lyons, Suzanne Laferté, (unknown), Lambert C. Loh	8
15	Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells 2003 ·Proceedings of the National Academy of Sciences ·Valentina Voigt, Catherine A. Forbes, Joanne Tonkin, Mariapia A. Degli‐Esposti, Hamish R.C. Smith, Wayne M. Yokoyama, Anthony A. Scalzo	152
16	Perforin Is a Major Contributor to NK Cell Control of Tumor Metastasis 1999 ·The Journal of Immunology ·Mark J. Smyth, Kevin Thia, Erika Cretney, Janice M. Kelly, Marie B. Snook, Catherine A. Forbes, Anthony A. Scalzo	246
17	TheCmv1Host Resistance Locus Is Closely Linked to theLy49Multigene Family within the Natural Killer Cell Gene Complex on Mouse Chromosome 6 1997 ·Genomics ·Catherine A. Forbes, Michael G. Brown, (unknown), Geoffrey Shellam, Wayne M. Yokoyama, Anthony A. Scalzo	56
18	Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes 1996 ·The Journal of Immunology ·Scott Thomson, (unknown), Martina A. Sherritt, Kathy Sproat, Barbara E.H. Coupar, Anthony A. Scalzo, Catherine A. Forbes, Andrew Ladhams, (unknown), Ralph A. Tripp, Peter C. Doherty, Dennis Moss, Andreas Suhrbier	103
19	DNA sequence and transcriptional analysis of the glycoprotein M gene of murine cytomegalovirus 1995 ·Journal of General Virology ·Anthony A. Scalzo, Catherine A. Forbes, Nicholas Davis‐Poynter, Helen E. Farrell, Paul Lyons	17
20	Prevalence of antibody to hepatitis A virus in Sri Lanka. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Yasuo Moritsugu, Kikuko Miyamura, Etsuko UTAGAWA, (unknown), (unknown), Catherine A. Forbes	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact